Indication: DLBCL
Title: Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)
Drug: selinexor

Please visit clinicaltrials.gov for more information about this study.

Phase IPhase IIPhase III
Phase I
Phase II
Phase III